Search Results - "OPIE, LIONEL H"
-
1
Metabolic mechanisms in heart failure
Published in Circulation (New York, N.Y.) (24-07-2007)“…Although neurohumoral antagonism has successfully reduced heart failure morbidity and mortality, the residual disability and death rate remains unacceptably…”
Get full text
Journal Article -
2
The Adrenergic-Fatty Acid Load in Heart Failure
Published in Journal of the American College of Cardiology (27-10-2009)“…The hypothesis proposed is that heart failure (HF) is associated with a reactive hyperadrenergic state that increases circulating plasma free fatty acids…”
Get full text
Journal Article -
3
Ischaemic postconditioning protects against reperfusion injury via the SAFE pathway
Published in Cardiovascular research (01-11-2009)“…Aims Ischaemic postconditioning (IPostC) is a powerful protective phenomenon that activates prosurvival intrinsic signalling cascades to limit reperfusion…”
Get full text
Journal Article -
4
Role of toll-like receptor 4 in melatonin-induced cardioprotection
Published in Journal of pineal research (01-01-2016)“…Melatonin protects the heart against myocardial ischemia/reperfusion injury via the activation of the survivor activating factor enhancement (SAFE) pathway…”
Get full text
Journal Article -
5
Metabolic management of acute myocardial infarction comes to the fore and extends beyond control of hyperglycemia
Published in Circulation (New York, N.Y.) (29-04-2008)Get full text
Journal Article -
6
Trimetazidine, a Metabolic Modulator, Has Cardiac and Extracardiac Benefits in Idiopathic Dilated Cardiomyopathy
Published in Circulation (New York, N.Y.) (16-09-2008)“…The anti-ischemic agent trimetazidine improves ejection fraction in heart failure that is hypothetically linked to inhibitory effects on cardiac free fatty…”
Get full text
Journal Article -
7
Present status of statin therapy
Published in Trends in cardiovascular medicine (01-04-2015)“…Abstract Statins are cardioprotective agents that reduce the adverse effects of increased low-density lipoprotein cholesterol (LDL-C) levels. For significantly…”
Get full text
Journal Article -
8
Role of melatonin, melatonin receptors and STAT3 in the cardioprotective effect of chronic and moderate consumption of red wine
Published in Biochemical and biophysical research communications (02-10-2015)“…We have recently discovered that melatonin, given acutely and directly to the isolated heart at the concentration found in wine, confers cardioprotection…”
Get full text
Journal Article -
9
A Proposal to Incorporate Trial Data Into a Hybrid American College of Cardiology/American Heart Association Algorithm for the Allocation of Statin Therapy in Primary Prevention
Published in Journal of the American College of Cardiology (22-09-2015)“…For primary prevention by a statin, a pre-treatment LDL-C level of 200 mg% (approximately 5 mmol/l) would substantially reduce the 10-year risk of a coronary…”
Get full text
Journal Article -
10
Is red wine a SAFE sip away from cardioprotection? Mechanisms involved in resveratrol- and melatonin-induced cardioprotection
Published in Journal of pineal research (01-05-2011)“…: Epidemiological studies suggest that regular moderate consumption of red wine confers cardioprotection but the mechanisms involved in this effect remain…”
Get full text
Journal Article -
11
Early Intravenous Beta-Blockade Before Primary Percutaneous Coronary Intervention Gives Major Benefits, Apparently Without Side Effects
Published in Journal of the American College of Cardiology (28-10-2014)“…The treated group had few side effects, namely reversible and nonfatal heart block and hypotension. [...]in 2 large studies, beta-blockade had side-effects to…”
Get full text
Journal Article -
12
Free fatty acid depletion acutely decreases cardiac work and efficiency in cardiomyopathic heart failure
Published in Circulation (New York, N.Y.) (14-11-2006)“…Metabolic modulators that enhance myocardial glucose metabolism by inhibiting free fatty acid (FFA) metabolism may improve cardiac function in heart failure…”
Get full text
Journal Article -
13
HDL protects against ischemia reperfusion injury by preserving mitochondrial integrity
Published in Atherosclerosis (01-05-2013)“…Abstract Objective High density lipoproteins (HDL) protect against ischemia reperfusion injury (IRI). However the precise mechanisms are not clearly…”
Get full text
Journal Article -
14
Interplay Between SAFE and RISK Pathways in Sphingosine-1-Phosphate–Induced Cardioprotection
Published in Cardiovascular drugs and therapy (01-06-2012)“…Purpose We studied the role of two powerful molecular signalling mechanisms involved in the cardioprotective effect of sphingosine-1-phosphate (S1P), a major…”
Get full text
Journal Article -
15
How strong is the evidence for use of beta-blockers as first-line therapy for hypertension? Systematic review and meta-analysis
Published in Journal of hypertension (01-11-2006)“…To quantify the effect of first-line antihypertensive treatment with beta-blockers on mortality, morbidity and withdrawal rates, compared with the other main…”
Get full text
Journal Article -
16
Very Early Administration of Glucose-Insulin-Potassium (GIK) by Emergency Medical Service for Acute Coronary Syndromes: Biological Mechanisms for Benefit in the IMMEDIATE Trial
Published in The American heart journal (01-08-2016)“…Abstract Aims In the IMMEDIATE Trial, intravenous glucose-insulin-potassium (GIK) was started as early as possible for patients with suspected acute coronary…”
Get full text
Journal Article -
17
Allopurinol for Heart Failure
Published in Journal of the American College of Cardiology (28-02-2012)“…[...]cytosolic CK then promotes the resynthesis of cytosolic ATP from cytosolic adenosine diphosphate, thus being an essential link in the overall sequence of…”
Get full text
Journal Article -
18
Postconditioning for protection of the infarcting heart
Published in The Lancet (British edition) (11-02-2006)“…Coronary heart disease is set to become the leading worldwide cause of death by 2020.1 Acute myocardial infarction is a major cause of such mortality and the…”
Get full text
Journal Article -
19
Beta-blockers for hypertension
Published in Cochrane database of systematic reviews (20-01-2017)“…Beta-blockers refer to a mixed group of drugs with diverse pharmacodynamic and pharmacokinetic properties. They have shown long-term beneficial effects on…”
Get more information
Journal Article -
20
Caloric Restriction Models Reverse Metabolic Syndrome
Published in Journal of the American College of Cardiology (10-03-2009)“…Another example of reversed metabolic syndrome is the acute inhibition of lipolysis by acipimox, which abruptly reduced circulating FFAs in obese patients with…”
Get full text
Journal Article